Carbocisteine Reduces Airway Mucus Obstruction and Alters Inflammatory Cell Populations in a Model of Muco‐Obstructive Lung Disease
Immunology & Cell Biology · 2026
DOI: 10.1111/imcb.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology & Cell Biology, 2026. Verfasst von Peter Ferris und 6 weiteren Autor:innen. Beteiligte Einrichtung: Airway Innate Immunity Group (AiiR), School of Medicine, Dentistry and Biomedical Sciences, Wellcome-Wolfson Institute for Experimental Medicine, Que…. Hauptthemen laut MEDLINE: Mucus, Carbocysteine, Lung Diseases, Obstructive, Expectorants. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department for the Economy Northern Ireland.
Abstract (Originalsprache)
Muco‐obstructive lung diseases, including chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and bronchiectasis, are characterized by excessive mucus production, airway surface dehydration, impaired mucociliary clearance, and progressive lung function decline. As the efficacy of current therapies often declines with muco‐obstructive disease progression, contributing significantly to morbidity and mortality, there is a need for improved treatments that address underlying defects in mucus homeostasis and airway physiology. In this study, we evaluate the effects of carbocisteine, a mucoactive therapeutic, in the βENaC‐transgenic (βENaC‐Tg) model of muco‐obstructive lung disease. Short‐term carbocisteine administration significantly reduced airway mucus obstruction, potentially through decreased concentrations of Muc5ac and Muc5b. Notably, carbocisteine treatment modulated key inducers of mucus production, such as interleukin (IL)‐13 and the upstream promoter cytokine IL‐17, suggesting broader effects on mucoregulatory pathways. Carbocisteine administration was observed to alter mononuclear cell populations, impacting specific inflammatory subsets of CD11b alveolar macrophages and Ly6c monocytes, indicating immunomodulatory effects, either directly or secondary to improved mucus clearance. However, despite changes in immune cell populations, short‐term administration failed to mitigate lung damage and inflammation associated with established muco‐obstructive lung disease. These findings demonstrate the potent mucoactive effect of carbocisteine in established muco‐obstructive lung disease, through a broader mechanism of action than previously understood, with the potential to modulate inflammatory responses for preventive or long‐term treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Airway Innate Immunity Group (AiiR), School of Medicine, Dentistry and Biomedical Sciences, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
- School of Medicine, Dentistry and Biomedical Sciences, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany.
- German Center for Lung Research (DZL), Associated Partner Site Berlin, Berlin, Germany.
- German Center for Child and Adolescent Health (DZKJ), Partner Site Berlin, Berlin, Germany.
ORCID-Profile: Clifford C Taggart
Förderung
- Department for the Economy Northern Ireland
Zitieren
APA
Ferris, P., Brown, R., McKelvey, M., McAuley, D. F., Mall, M. A., Connolly, B., & Taggart, C. C. (2026). Carbocisteine Reduces Airway Mucus Obstruction and Alters Inflammatory Cell Populations in a Model of Muco‐Obstructive Lung Disease. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70156
Vancouver
Ferris P, Brown R, McKelvey M, McAuley DF, Mall MA, Connolly B, et al. Carbocisteine Reduces Airway Mucus Obstruction and Alters Inflammatory Cell Populations in a Model of Muco‐Obstructive Lung Disease. Immunology & Cell Biology. 2026. doi:10.1111/imcb.70156
BibTeX
@article{Ferris2026,
author = {Ferris, Peter and Brown, Ryan and McKelvey, Michael and McAuley, Daniel F and Mall, Marcus A and Connolly, Bronwen and Taggart, Clifford C},
title = {Carbocisteine Reduces Airway Mucus Obstruction and Alters Inflammatory Cell Populations in a Model of Muco‐Obstructive Lung Disease},
journal = {Immunology & Cell Biology},
year = {2026},
doi = {10.1111/imcb.70156}
}
EUVIMED